Thierry Pieton - Mar 3, 2025 Form 4/A - Amendment Insider Report for Medtronic plc (MDT)

Role: EVP & Chief Financial Officer
Signature: /s/ Thomas L. Osteraas, attorney-in-fact
Stock symbol: MDT
Transactions as of: Mar 3, 2025
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 3/10/2025, 05:02 PM
Date Of Original Report: Mar 5, 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MDT	Ordinary Shares	Award	$0	+4.24K		$0.00	4.24K	Mar 3, 2025	Direct	F1, F2
transaction	MDT	Ordinary Shares	Award	$0	+26.5K	+624.99%	$0.00	30.8K	Mar 3, 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MDT	Stock Option (Right to Buy)	Award	$0	+29.6K		$0.00	29.6K	Mar 3, 2025	Ordinary Shares	29.6K	$94.30	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Form 4 filed 3/5/2025 reported incorrect vesting information for restricted stock units due to an administrative error. The purpose of this amendment is to correct the vesting description to state: Represents restricted stock units that vest 100% on July 29, 2027.
F2	Form 4 filed 3/5/2025 reported incorrect pricing information for restricted stock units due to an administrative error. The purpose of this amendment is to reflect that restricted stock units were received as a grant, for no consideration.
F3	Form 4 filed 3/5/2025 reported incorrect vesting information for options due to an administrative error. The purpose of this amendment is to correct the vesting description to state: The options are exercisable in four equal annual installments on July 29th of 2025, 2026, 2027 and 2028.